Model-informed COVID-19 vaccine prioritization strategies by age and serostatusKate M. Bubar, Daniel B. Larremore, Yonatan H. Grad et al.|Science|2021Cited by 846
Model-informed COVID-19 vaccine prioritization strategies by age and serostatusKate M. Bubar, Daniel B. Larremore, Sarah Cobey et al.|medRxiv|2020Cited by 155
Estimating SARS-CoV-2 seroprevalence and epidemiological parameters with uncertainty from serological surveysDaniel B. Larremore, Yonatan H. Grad, Bailey K. Fosdick et al.|eLife|2021Cited by 100
Estimating SARS-CoV-2 seroprevalence and epidemiological parameters with uncertainty from serological surveysDaniel B. Larremore, Yonatan H. Grad, Bailey K. Fosdick et al.|medRxiv|2020Cited by 46
Implications of Test Characteristics and Population Seroprevalence on “Immune Passport” StrategiesDaniel B. Larremore, Yonatan H. Grad, Kate M. Bubar|Clinical Infectious Diseases|2020Cited by 20